TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
Patient portrayal.
Individual results may vary.
Savings & Support
Concerned about cost and access? We're here for you and your patients
TRINTELLIX is available for ~85% of commercially insured patients in the United States without prior authorization (PA)*
The TRINTELLIX Savings Card may help your adult patients pay less for their prescriptions†
- Eligible adult patients may pay as little as $10 per 30- or 90-day prescription†
- 77% of commercial patients pay $10 or less
†Only commercially insured patients ages 18 or older are eligible for the TRINTELLIX Savings Card. Savings up to $100 per 30-day or $300 per 90-day prescription. See Savings Card for full Eligibility Requirements and Terms & Conditions.
*Formulary data are provided by Fingertip Formulary® and are current as of September 2022. Check patient’s individual health plan for coverage and cost information, which may change without notice.
Is your office running low on TRINTELLIX samples? Just visit MySampleCloset and
follow the steps below.
- Login or register to create a new account (upon login, you may be prompted to complete a few security questions)
- View the list of products and select TRINTELLIX
- Place and submit your order. Maximum order quantities are listed on the site, one order may be placed per month.
Please note that when a TRINTELLIX sample order is placed on the MySampleCloset website, your local Takeda representative will be notified so that they can expedite delivery by bringing them to your office personally. If the representative is unable to deliver your order, the samples will be shipped to your office.
Prior Authorization Assistance
For patients who require PA, PARx Solutions may be able to help. The user-friendly portal helps initiate and manage PAs while also helping ensure the accuracy of administrative components of the PA submission.
Submit a PA today at www.PARxSolutions.com
TRINTELLIX offers support for patients with MDD
When enrolled, patients can customize their experience through support tools like:
Mobile wallet
Must meet eligibility requirements.
Informative emails
Inspiring texts and refill reminders
Chats with a tAccess advisor
1-844-654-TRIN - 8:00 am - 8:00 pm ET M-F (1-844-654-8746)
We are committed to partnering with you to help provide support for MDD patients:
- Education around the symptoms of Major Depressive Disorder
- Encouragement of dialogue with you, their healthcare professional
- Tips and tools that reinforce the conversations you have with your patients
Michele Novella, APRN‑BC
Fairfield University, Medical Director and Owner of Star Psychiatric Healthcare, LLC, Danbury, Connecticut
"These services are designed to give patients access to more information and support."
Michele Novella, APRN-BC, is the medical director and owner of Star Psychiatric Healthcare in Danbury, CT. She is a past member of Western Connecticut Health Network’s (WCHN) medical staff where she worked in the Behavioral Health Department including Crisis Intervention, Intensive Outpatient Program running groups and teaching Dialectical Behavioral Therapy (DBT). In the Outpatient setting, Michele held several critical incident debriefings following traumatic events and losses that were experienced by the staff there.
After graduating from Fairfield University, Michele worked as a Registered Nurse at Memorial Sloan-Kettering Cancer Center in New York City. Later, she worked at WCHN’s inpatient oncology unit before being asked to serve as Nurse Manager for the Outpatient Oncology & Chemotherapy Infusion Services at Associated Internists of Danbury. During that time, she received the prestigious American Cancer Society’s State‑Wide “Excellence in Oncology Nursing Award” in 1991.
Michele later pursued her Master’s Degree of Nursing from Yale University, graduating with Honors. She is Board Certified by the ANCC as both a Clinical Nurse Specialist in Adult Psychiatric Nursing, as well as a Psychiatric Nurse Practitioner.
She holds specialized training in DBT and cognitive behavioral therapy (CBT) and Critical Incident Stress Debriefing. She held a pivotal role in the aftermath of the Sandy Hook Shootings and helped to organize and run the crisis services offered to the public at Newtown’s Reed Intermediate School and treated several of the Newtown Police Department’s first responders. She has been asked to speak to several groups on post‑traumatic stress disorder and stress responses after trauma.
Ms Novella was paid as a consultant for Takeda and Lundbeck.
Jay Fawver, MD
Indiana University, Parkview Physicians Group Mind-Body Medicine, Fort Wayne, Indiana
"In my practice we ensure each patient received information about the tAccess support program after their first appointment where they are prescribed TRINTELLIX. Given the high rate of virtual appointments being conducted today, this program provides an additional layer of support and contact for patients."
Jay D. Fawver, MD, is the medical director at Parkview Mind‑Body Medicine in Fort Wayne, IN. At Mind‑Body Medicine, he orchestrates the treatment of over 8000 current patients in a shared pharmacological treatment model. He works with 10 nurse practitioners, assisted by nurses and medical assistants, utilizing customized electronic medical records to coordinate consistent clinical care with personalized and precision treatment strategies. His nurse practitioners provide integrated treatment by having access to direct consultation with Dr Fawver and the other nurse practitioners while utilizing treatment algorithms for various conditions and genetic profiles. Patients are monitored for treatment response and recovery utilizing patient-rated outcome metrics for mood, anxiety, cognition, insomnia, daily functioning, and side effects.
Since March 2020, Mind-Body Medicine has initiated telehealth for a majority of outpatients utilizing the new Epic Video Client internet platform. Utilizing this platform from their smartphones, tablets, or laptops, patients are prompted to complete outcome questionnaires on their MyChart portals 1 to 2 days prior to each appointment. These outcome metrics include the PHQ-9, GAD-7, Perceived Deficits Questionnaire (PDQ-20), Insomnia Severity Index (ISI), Work and Social Adjustment Scale (WSAS), and Patient Rated Inventory of Side Effects (PRISE), guiding treatment decisions and enhancing the efficiency of the outpatient video visit. Dr Fawver is a clinical professor of psychiatry at the Indiana University School of Medicine and is board certified by the American Board of Psychiatry and Neurology. He has been named a Distinguished Life Fellow of the American Psychiatric Association. A graduate of Purdue University School of Pharmacy, Dr Fawver was a pharmacist prior to his medical training. He has been an advisor to several pharmaceutical companies for over 30 years, participating as a principal investigator and assisting in the development of medication studies and outcomes of disease states such as depression, bipolar disorder, schizophrenia, and fibromyalgia with more recent work involving genetic correlations with medication treatment outcomes.
Since October 2019, Dr Fawver has been a certified Epic Physician Builder where he designs computer programs for charting in the electronic medical records based upon best practice guidelines.
Since 1997, he has been the host and producer of the Public Broadcasting System’s Matters of the Mind with Dr Jay Fawver, a weekly 30-minute live call-in television program addressing mental health topics.
Dr Fawver was paid as a consultant for Takeda and Lundbeck.
Savings & support resources for your patients
Patient profile
Learn more about a patient
living with MDD.
Patient coverage
in your area
Find out about formulary coverage in your area for TRINTELLIX.
Telling patients
about telehealth
As telehealth visits become more common, it’s important to have helpful resources for you and your patient.
Prescription
savings for your
eligible patients
Find out about savings and support offered through tAccess by reading the Savings Card brochure.
Safety profile
See how the safety profile fits in the story.
Long-term
clinical data
Results from multiple clinical studies of TRINTELLIX.
Offering
patients once
daily dosing
Learning about dosage amounts and drug interactions.
Request a
rep visit
Connect with a TRINTELLIX representative.
Support for
your patients
We’re here to help your eligible patients get the treatment you prescribe.